{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:39:04Z","timestamp":1791247144734,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.bcmd.2010.10.016","type":"journal-article","created":{"date-parts":[[2011,1,22]],"date-time":"2011-01-22T04:37:40Z","timestamp":1295671060000},"page":"189-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis"],"prefix":"10.1016","volume":"46","author":[{"given":"Erfan","family":"Nur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard J.","family":"van Beers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuena","family":"Martina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Cuccovillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Martin","family":"Otten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-John B.","family":"Schnog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost C.M.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dees P.","family":"Brandjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.","family":"Biemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2010.10.016_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1096-8652(199805)58:1<61::AID-AJH11>3.0.CO;2-8","article-title":"New concepts in assessing sickle cell disease severity","volume":"58","author":"Schnog","year":"1998","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.02557.x","article-title":"The emerging understanding of sickle cell disease","volume":"112","author":"Serjeant","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0015","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.10.016_bb0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2141.1994.tb08317.x","article-title":"The painful crisis of homozygous sickle cell disease: clinical features","volume":"87","author":"Serjeant","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0030","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.V75.1.274.274","article-title":"Magnetic resonance imaging of bone marrow in sickle cell disease: clinical, hematologic, and pathologic correlations","volume":"75","author":"Mankad","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.10.016_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-007-9126-7","article-title":"Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3","volume":"28","author":"Mantovani","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0050","doi-asserted-by":"crossref","first-page":"32817","DOI":"10.1074\/jbc.272.52.32817","article-title":"Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component","volume":"272","author":"Bottazzi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0055","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/00003246-200107000-00017","article-title":"Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients","volume":"29","author":"Muller","year":"2001","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0060","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","article-title":"PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation","volume":"44","author":"Fazzini","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2249.2000.01110.x","article-title":"Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)","volume":"119","author":"Luchetti","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.102.6.636","article-title":"PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans","volume":"102","author":"Peri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2010.10.016_bb0075","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","article-title":"Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction","volume":"110","author":"Latini","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2010.10.016_bb0080","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/eji.200324390","article-title":"Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells","volume":"33","author":"Doni","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2005.11.009","article-title":"Pentraxins as a key component of innate immunity","volume":"18","author":"Bottazzi","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0095","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.ATV.0000012282.39306.64","article-title":"Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation","volume":"22","author":"Napoleone","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1189\/jlb.1003528","article-title":"The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation","volume":"76","author":"Napoleone","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.10140","article-title":"Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors","volume":"70","author":"Powars","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI9225","article-title":"Hypoxia\/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice","volume":"106","author":"Kaul","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0115","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0002-9440(10)62318-8","article-title":"Transgenic sickle mice are markedly sensitive to renal ischemia\u2013reperfusion injury","volume":"166","author":"Nath","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0120","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0002-9440(10)61122-4","article-title":"Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury","volume":"160","author":"Souza","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0125","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2353\/ajpath.2009.080240","article-title":"The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice","volume":"174","author":"Souza","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0130","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3324\/haematol.2009.008938","article-title":"Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease","volume":"94","author":"van Beers","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2010.10.016_bb0135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/156652408786241366","article-title":"Hypercoagulability in sickle cell disease and beta-thalassemia","volume":"8","author":"Singer","year":"2008","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V100.3.879","article-title":"Pro-oxidant and cytotoxic effects of circulating heme","volume":"100","author":"Jeney","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.10.016_bb0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archinte.166.3.366","article-title":"C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell disease","volume":"166","author":"Makis","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0150","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1182\/blood-2004-12-4676","article-title":"Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome","volume":"105","author":"Bargoma","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.10.016_bb0155","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.107.749234","article-title":"Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction","volume":"117","author":"Salio","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2010.10.016_bb0160","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1097\/CCM.0b013e3181809aaf","article-title":"Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity","volume":"36","author":"Mauri","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bcmd.2010.10.016_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/SHK.0b013e31817fd543","article-title":"Pentraxin 3 and C-reactive protein in severe meningococcal disease","volume":"31","author":"Sprong","year":"2009","journal-title":"Shock"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:27:30Z","timestamp":1761049650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979610002573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1079979610002573"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.016","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}